Puya Aravand

Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

Jean Bennett, Jennifer Wellman, Kathleen Marshall et al. · The Lancet · 2016 · 456 citations · Full text

Medicine, Genetics, Ophthalmology +16

Plasticity of the human visual system after retinal gene therapy in patients with Leber’s congenital amaurosis

Manzar Ashtari, Hui Zhang, Philip A. Cook et al. · Science Translational Medicine · 2015 · 63 citations

Medicine, Neuroscience, Ophthalmology +17

The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients

Manzar Ashtari, Elena S. Nikonova, Kathleen Marshall et al. · Ophthalmology · 2017 · 43 citations

Medicine, Neuroscience, Ophthalmology +17

Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1

Ahmara G. Ross, Devin S. McDougald, Reas S. Khan et al. · Gene Therapy · 2021 · 38 citations · Full text

Medicine, Molecular Medicine, Ophthalmology +17

Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital Blindness

Ji Yun Song, Puya Aravand, Sergei Nikonov et al. · Molecular Therapy · 2018 · 27 citations · Full text

Medicine, Genetics, Ophthalmology +17